Important information about the Coronavirus (COVID-19)

Until further notice all of our Queue & Wait, Test & Go and routine appointment services are suspended to help reduce the spread of Coronavirus (COVID-19) and to enable some of our staff to be re-deployed. This means that you are unable to be seen in the clinic without talking to our central booking team first.

Please call 01904 721111 (9am - 3pm) Monday to Friday to arrange a discussion with one of our clinical staff. If you feel the issue is URGENT e.g. you need emergency contraception, HIV post-exposure treatment or have new and significant symptoms, please let the booking team know. Our 'contact us' option on the website can be used but there may be some delays in responding to non-urgent queries. We are closed over the Easter Bank Holiday weekend

Clinic Closures -  we are currently only operating clinics in York, Selby, Harrogate, Scarborough, Northallerton, Catterick and Skipton - all other clinics are temporarily suspended.

ONLINE SERVICES - free condoms are available via the website for residents of York and North Yorkshire. Online testing is available for those most at risk of STIs or who have been advised to do a test

Close

For information on coronavirus (COVID-19), please visit https://www.yorsexualhealth.org.uk/coronavirus-corvid-19-information/

Professionals

I would like to see current sexual health news

April 2020 - Coronavirus (Covid-19) guidance for professionals

The ADPH UK - COVID-19 guidance/ recommendations on the Prioritisation of Sexual & Reproductive Health Services has just been published, as four downloadable PDF docs.

FSRH advice for women seeking contraception, abortion and SRH advice during the COVID-19 pandemic

FPA/Sexwise unplanned pregnancy/abortion and Covid-19

BASHH support for local responses to COVID-19 and contingency planning

NHS Cervical Screening Programme Guidance for Sample Taking during Coronavirus pandemic

Safe sex reminder as antibiotic resistant gonorrhoea investigations continue

Public Health England (PHE) is issuing a reminder to the public to practise safe sex by using a condom with new or casual partners.

The call comes as an increase in antibiotic resistant cases of gonorrhoea continues, a further sign of the very real threat of antibiotic resistance to our ability to treat infections.

Finding this sort of extensively drug resistant gonorrhoea in the UK serves as an important reminder of the need to practice safer sex. This includes using condoms consistently and correctly with all new and casual sexual partners. Anyone with symptoms of a sexually transmitted infection (STI) or who is concerned they may have an STI should seek advice from their sexual health clinic.

For more information visit https://www.gov.uk/government/news/two-cases-of-resistant-gonorrhoea-diagnosed-in-the-uk

At the present time, the advice to frontline clinicians remains unchanged - as before we would still be advising all cases of suspected/confirmed gonorrhoea to be referred to local sexual health services for appropriate management, encouraging regular STI testing and protected sex with condoms.

Chlamydia treatment guidelines changed in September 2018

BASHH:

Chlamydia treatment guidelines changed in September 2018:

First line treatment is Doxycycline 100mg bd for seven days (contraindicated in pregnancy) and second line treatment is  Azithromycin 1g orally as a single dose, followed by 500mg once daily for two days

Publication of updated guideline for the management of infection with Neisseria gonorrhoeae (2019) The updated guideline for the management of infection with Neisseria gonorrhoeae is available at https://www.bashh.org/guidelines Changes since the 2011 guideline include: •    First line empirical treatment is now monotherapy with ceftriaxone 1g  •    If antimicrobial susceptibility test results from all sites of infection are available prior to treatment and the isolate is sensitive to ciprofloxacin, then this should be used for treatment in preference to ceftriaxone •    Recommendations for extra-genital testing in those with suspected or confirmed antimicrobial resistance  •    Epidemiological treatment is recommended only for those presenting within 14 days of exposure. For those presenting after 14 days of exposure we recommend treatment based on the results of testing.

The recent changes from the Neisseria gonorrhoeae, chlamydia treatment guidelines and the publication of BASHH Mycoplasma genitalium guidelines have impacted upon the first line treatment for Pelvic inflammatory disease, non-gonococcal urethritis. Please see BASHH website for the guidelines: https://www.bashh.org/guidelines

FRSH:

Combined Hormonal Contraception

The FSRH CHC Clinical Guideline is now available on the FSRH website  https://www.fsrh.org/news/fsrh-publishes-clinical-guideline-on-combined-hormonal/

What is new in this guideline?